• 6th ANNUAL PHARMA GMP & QUALITY MANAGEMENT 2026
    23rd - 24th April, Mumbai
  • 6th ANNUAL PHARMA GMP & QUALITY MANAGEMENT 2026
    23rd - 24th April, Mumbai
  • 6th ANNUAL PHARMA GMP & QUALITY MANAGEMENT 2026
    23rd - 24th April, Mumbai
  • 6th ANNUAL PHARMA GMP & QUALITY MANAGEMENT 2026
    23rd - 24th April, Mumbai
  • 6th ANNUAL PHARMA GMP & QUALITY MANAGEMENT 2026
    23rd - 24th April, Mumbai

About the event

Following the resounding success of its 5th edition, Eminence Business Media proudly presents the 6th Annual Pharma GMP and Quality Management 2026, scheduled for 23rd - 24th April at The Westin Mumbai Garden City.

This confluence is dedicated to fostering the exchange of knowledge, embracing best practices, and enhancing the capabilities of pharmaceutical companies in India, empowering them to adopt globally recognized standards with a strong emphasis on the technical intricacies of pharmaceutical manufacturing and quality assurance. This highly anticipated occasion will provide a comprehensive platform for industry experts to converge and delve deep into the technical nuances of Good Manufacturing Practices (GMP) and quality management.

The session is aiming to showcase in-depth discussions and immersive training sessions led by renowned thought leaders and practitioners to gain practical, technical skills and knowledge essential for ensuring compliance, product quality, and operational efficiency in pharma manufacturing.

To enhance the learning experience and better understanding and implementation, a virtual session is to take place on 23rd - 24th April, 2026 with additional presentation and follow up question answer round with 3 industry experts.

Let's connect and collaboratively shape the success of the 6th Annual Pharma GMP and Quality Management 2026.

The conference is co-located with The Pharma Quality Excellence Awards 2025 at The Westin Mumbai Garden City.



Benefits of Partnering

Access to Decision Makers and Influencers: 150+ decision-makers and influencers in the conference hall can lead to potential collaborations, partnerships, and business opportunities.
International and Indian Pharma Companies Networking: Opens doors to global markets, foster cross-border collaborations, and facilitate knowledge exchange on a global scale.
Extensive Media Coverage: Enhance the visibility of partnering companies and position yourself as a market leader.
Post-Event Assistance and Support: Includes follow-up meetings, additional information sharing, and assistance in navigating post-conference business transactions, strengthening the value of the partnership.
Focused Networking Opportunities: Engage with specific individuals or companies relevant to their business goals, optimizing their networking efforts for targeted outcomes.
Limited Vendors from the Same Category: Exclusivity can enhance the visibility of each vendor and prevent saturation, making the partnership more valuable for participants.

Why Attend?

  • In-depth discussions, case studies, group discussions and dedicated Q&A session for enhanced practical learning.
  •  Explore the impact of recent innovations in GMP & Quality Management 
  • Gain insights through interactive live Q&A sessions and enjoy the advantage of extended 6-month support for continuous learning.
  • Follow up virtual learning session with presentations and dedicated Q&A round 15 days after the conference.
  •  Network with your industry peers and understand what they do differently

Attendee Profile ?

Managing Directors, Directors, CXO’s, President, Sr. VP’s, VP’s, GM’s, Sr. Managers Managers and professionals from:

Quality Assurance
Quality Control
Quality Compliance
Clinical Trials/Clinical Quality/Clinical Operations
Regulatory Affairs
Quality Audits
Anyone who follows, and has to be compliant with GMP, GCP & Quality Management regulations.

Pricing

$ 1200 / INR 50,000

Standard Pricing

  • + 18% GST applicable
$ 1350 / INR 60000

Onsite Registration

  • + 18% GST applicable

*These prices are applicable for pharmaceutical companies only.

SPEAKERS

Ashok Nayak


CIO
Ipca Laboratories

View Profile
×
Raj Kumar Patra

Ashok Nayak

CIO - Ipca Laboratories

Ashok Nayak is a seasoned technology leader with over two decades of expertise in driving digital transformation and IT innovation within the pharmaceutical industry. Currently serving as the Chief Information Officer at Ipca Laboratories Limited, he has been instrumental in shaping the company’s IT landscape since 2000, steadily advancing from his role as General Manager – IT to spearheading strategic initiatives as CIO.
Throughout his career, Ashok has demonstrated a strong ability to align business objectives with technology solutions, ensuring that IT remains a core enabler of growth, efficiency, and compliance in a highly regulated industry. His leadership has been pivotal in modernizing IT operations, enhancing data-driven decision-making, and fostering a culture of continuous innovation.
Ashok’s academic journey reflects his commitment to lifelong learning and excellence. He holds an MBA in Information Technology from ICFAI University, a General Management Programme certification from IIM Indore, and has enriched his global perspective with a Digital Transformation program at Cornell University.
With core skills in project management, leadership, and team management, Ashok is deeply passionate about leveraging emerging technologies to optimize processes and create sustainable value. Based in Mumbai, he continues to lead transformative initiatives that empower both business and technology at Ipca.

Ken Shitamoto

Executive Director, IT Quality & Compliance
Gilead Lifesciences

View Profile
×
Ken Shitamoto

Ken Shitamoto

Executive Director, IT Quality & Compliance – Gilead Lifesciences

Ken Shitamoto leads the IT Quality and Compliance group at Gilead Sciences, which includes Privacy, Quality Assurance and Quality Engineering. He is a member of the GAMP America's Steering Committee, Co-Lead of the GAMP CSA SIG, and a member of the FDA-Industry CSA team. He is contributing author to GPG Data Integrity by Design (CSA Appendix), GPG Enabling Innovation, and GAMP5 v2.
He holds a BA Molecular Cell Biology and MS Computer Science and from UC Berkeley and San Jose State University respectively.

Milind Goverdhan Gujar


Chief Quality Officer
RPG Life Sciences Ltd.

View Profile
×
Milind Gujar

Milind Goverdhan Gujar

Chief Quality Officer – RPG Life Sciences Ltd.

Milind Goverdhan Gujar is the Chief Quality Officer (QA & QC) at RPG Life Sciences Ltd., where he has been a member of the Executive management committee since 2019. He is a seasoned pharmaceutical quality professional with over 37 years of experience in Active Pharmaceutical Ingredients (API), Bio technology and Formulation quality functions.
Holding an Masters in Analytical Chemistry, Milind has worked in various capacities within the quality sector at multiple reputable organizations, including Emcure, Micro Labs, Reliance Life Sciences, Cipla, Famy care and Ipca, prior to joining RPG Life Sciences His extensive professional experience covers API, Formulations, and Biopharmaceutical products.
Milind is recognized for his expertise in handling digitalization projects for large organizations, such as implementing Track and Trace, Trackwise, LIMS, and paperless laboratory concepts along with Quality function.
He has also handled various green field and brown field projects for his previous organisation specifically oncology and hormone projects. He has successfully managed a significant number of audits from global regulatory bodies, including the USFDA, EDQM, EUGMP, MHRA, WHO Geneva, Anvisa Brazil and Health Canada. He is also an invited speaker at various seminars, particularly on the topics of Quality and the Digitalization of Quality Management Systems (QMS)

Raj Kumar Patra

Product Group Lead – Data, Quality & EHS
Reckitt

View Profile
×
Raj Kumar Patra

Raj Kumar Patra

Product Group Lead – Data, Quality & EHS – Reckitt

With over two decades of Technology & Digital leadership in pharma and consumer healthcare, Raj Kumar Patra specializes in driving digital transformation, AI-powered innovation, and enterprise IT strategy to enable business growth, compliance, and operational excellence. As Head of IT for Research Services at Syngene International, he oversees portfolios spanning Chemistry, Biology, Clinical Research, Safety Assessment & Computational Data Science—integrating AI, data analytics, automation, cybersecurity, and cloud technologies to deliver transformative outcomes.
A strong advocate for AI and data-led decision-making, he has implemented predictive analytics and enterprise data governance strategies to enhance compliance, efficiency, and agility.
He thrives at the intersection of technology, business, and regulatory standards, shaping the future of enterprise IT.

Sanjay Sharma

Senior VP & Head – Manufacturing Science and Technology
Zydus Group

View Profile
×
Sanjay Sharma

Sanjay Sharma

Senior VP & Head – Manufacturing Science and Technology – Zydus Group

Sanjay Sharma, a future-ready CIO, aligns IT strategy with business growth and innovation. With 25 years of leadership in the pharmaceutical and manufacturing sectors, Sanjay brings deep expertise in driving digital transformation in highly regulated industries. He has successfully led large-scale technology initiatives, enabling organizations to unlock growth opportunities while ensuring compliance and operational excellence. Recognized as a trusted C-suite advisor, Sanjay specializes in shaping digital roadmaps, leveraging cutting-edge solutions, and delivering enterprise-wide transformation that creates lasting business value.

Sudhir Bhandare

Executive Director & Head of
Technical Operations
Sandoz

View Profile
×
Sudhir Bhandare

Sudhir Bhandare

Executive Director & Head of Technical Operations – Sandoz

Sudhir Bhandare is a seasoned pharmaceutical leader with over three decades of experience driving operational excellence and advancing access to high-quality medicines worldwide. A pharmacist by education (M.Pharm) with an MBA, he brings together deep technical expertise and strategic business acumen.
Throughout his career, Sudhir has evolved from strong technical foundations in pharmaceutical formulations to senior leadership roles marked by strategic vision, execution excellence, and transformative impact. He has led high-impact initiatives, strengthened operational performance, and mentored future leaders, consistently embracing change and growth at every stage of his professional journey.
Prior to his current role as Executive Director & Head of Technical Operations at Sandoz, Sudhir built a distinguished career with leading global pharmaceutical organizations including GSK (GlaxoSmithKline), Schering-Plough, Mylan, Novartis, Glenmark, and Ipca. His core expertise spans operational excellence, large-scale execution, and formulation science, underpinned by a strong commitment to quality and performance.
At the heart of Sudhir’s leadership philosophy is a powerful purpose: ensuring equitable access to affordable, high-quality medicines across geographies. He firmly believes that healthcare is a right, not a privilege, and is dedicated to bridging the gap between innovation and accessibility to improve the quality of human life globally.
Beyond the boardroom and manufacturing floor, Sudhir channels the same discipline and consistency into personal fitness—balancing his professional dedication to healing others with a personal commitment to self-improvement and well-being.

Dr. V. Kalaiselvan

Secretary-cum-Scientific Director
IPC, Ministry of Health & Family Welfare, Government of India

View Profile
×
Dr. V. Kalaiselvan

Dr. V. Kalaiselvan

Secretary-cum-Scientific Director – IPC, Ministry of Health & Family Welfare, Government of India

Dr. V. Kalaiselvan is currently serving as the Secretary-cum-Scientific Director of the Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare, Government of India. He holds a Ph.D. in Pharmaceutical Sciences from the University of Delhi. Dr. Kalaiselvan has been associated with IPC since 2009, contributing significantly to the domains of pharmacopoeial standards, rational use of medicines, drug safety, and regulatory systems.
He played a key role in the conceptualization and nationwide implementation of the Pharmacovigilance Programme of India (PvPI) and the Materiovigilance Programme of India (MvPI), which have strengthened India’s surveillance framework for the safety of medicines and medical devices.
Dr. Kalaiselvan has represented IPC on various national and international platforms, including the World Health Organization (WHO), and continues to contribute to global initiatives for strengthening pharmacovigilance systems in low- and middle-income countries. In recognition of his work, the WHO Headquarters in Geneva acknowledged him as one of the significant contributors to global pharmacovigilance in their 50th Celebratory Album of the International Drug Monitoring Programme.
He has authored 11 chapters and published over 130 research and review articles in national and international journals. He is also a recipient of prestigious fellowships awarded by the Department of Science & Technology (DST) and the All India Council for Technical Education (AICTE).

Vipul Doshi


Chief Quality Officer
Zydus Group

View Profile
×
Vipul Doshi

Vipul Doshi

Chief Quality Officer – Zydus Group

Mr. Vipul Doshi has been in pharmaceutical Industry from more than three decades with diverse leadership and operational expertise across development, manufacturing, R&D, GXP quality assurance (QA) and manufacturing operations (parenterals, solid dosage forms, biotechnology, transdermal, biologics and vaccines.
He has been leading the Quality and Regulatory affairs function in the Pharmaceutical Companies of high credentials. Throughout his career he has been providing passionate global leadership and pioneered in guiding the companies to meet the Global Regulatory, Quality Standards and Compliance requirements.
He has been a Great Contributor in developing and implementing Quality attributes and Culture of Excellence based upon a set of core values and ethical practices, which integrate and improve business operations and enhance the compliance within the Organization.
He has been a leading advocate for Global Competitiveness and instrumental in due diligence for various acquisitions and mergers. He possesses great expertise in Projects and Engineering for developing Infrastructures for APIs and Drug Products (Sterile and Non Sterile). He has been actively involved with various professional associations like ISPE/PDA/AAM.
Associated with varied Roles and increasing responsibilities he is currently Chief Quality & Compliance Officer at Zydus Lifesciences Limited (Company has headquarters at Ahmedabad). He also Leads IRA, Research and Development functions for Active Pharmaceutical Ingredient, Environment Health & Safety and Pharmacovigilance.
Zydus Lifesciences Limited is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employs nearly 25000 people worldwide and is dedicated to creating healthier communities globally.
The Product portfolio ranges from Complex generics Sterile and Non Sterile, Biologics and Vaccines and various dosage forms catering to the global market.

PARTNERS

SILVER PARTNER

ETQ

Veeva

Veeva Systems – Transforming Pharma through Cloud-Based Automation and Innovation.
Veeva Systems is a global leader in cloud-based software solutions for the life sciences industry. With a mission to help companies bring medicines and therapies to patients faster and more efficiently, Veeva delivers a comprehensive suite of solutions that spans the full product lifecycle—from research and development to commercialization.
Our industry-specific solutions are designed to meet the unique regulatory, quality, and compliance needs of pharmaceutical, biotech, and medical device companies. Veeva’s flagship applications, including Veeva Vault—the only cloud-based platform tailored for regulated industries—enable organizations to unify content and data management, streamline processes, and drive automation across the enterprise.
With deep expertise in the domains of quality, regulatory, clinical, commercial, and medical affairs, Veeva is trusted by more than 1,400+ companies globally, including emerging biotechs and the world’s largest pharmaceutical enterprises. Our suite of Quality applications, including Vault QMS, Vault QDocs, and Vault Training, Vault Validation Management, Valult LIMS, Vault Station Manager and Learn GxP is transforming the way life sciences companies manage quality processes, improving compliance, efficiency, and innovation.
Veeva’s commitment to customer success drives us to continuously innovate. Our cloud platform’s scalability, built-in compliance, and industry best practices help companies adapt to regulatory changes, reduce operational risks, and accelerate time to market.
Headquartered in Pleasanton, California, with offices around the world, Veeva Systems is dedicated to advancing the life sciences industry through automation, innovation, and collaboration.
Learn More



MEDIA PARTNERS

PAST EVENT PARTNERS